Quarterly report pursuant to Section 13 or 15(d)

Financial Information Relating to Reportable Segments (Detail)

v2.4.0.6
Financial Information Relating to Reportable Segments (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Segment Reporting Information [Line Items]        
External sales $ 75,083 $ 74,662 $ 150,108 $ 152,258
Earnings before income taxes 37,446 37,873 75,432 78,373
Biotechnology
       
Segment Reporting Information [Line Items]        
External sales 69,628 69,808 139,131 142,111
Earnings before income taxes 36,883 37,878 73,877 77,862
Hematology
       
Segment Reporting Information [Line Items]        
External sales 5,455 4,854 10,977 10,147
Earnings before income taxes 2,148 1,681 4,251 3,599
Reportable Segment
       
Segment Reporting Information [Line Items]        
Earnings before income taxes 39,031 39,559 78,128 81,461
Unallocated Amount to Segment
       
Segment Reporting Information [Line Items]        
Earnings before income taxes $ (1,585) $ (1,686) $ (2,696) $ (3,088)